SENS - NASDAQ
Senseonics Holdings, Inc.
$6.72
-2.2%Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
At a Glance
Live SnapshotSenseonics Holdings, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Flat FCF growth. Stable but not expanding—monitor for signs of business maturity or temporary headwinds.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
Senseonics Holdings, Inc. Cash Flow Statement
SENS • NASDAQ
| Senseonics Holdings, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||||||
-69.1M | -78.6M | -60.4M | 142.1M | -302.5M | -175.2M | -115.5M | -94M | -59.1M | -43.9M | -29.9M | -18.9M | -18.8M | |
91K | 1.5M | 1.3M | 985K | 1.2M | 1.1M | 1M | 270K | 227K | 155K | 118K | 189K | 220K | |
0.0 | 0.0 | 0.0 | 0.0 | 229.2M | 61.8M | 0.0 | -123K | 98K | 430K | -46K | -8K | 0.0 | |
10.2M | 9.2M | 8.7M | 8.6M | 9M | 7.3M | 8.1M | 6.4M | 4M | 2.4M | 1.4M | 539K | 450K | |
3M | 6.6M | -15.8M | -215.6M | 8.5M | 23.7M | -20.1M | 3.3M | 453K | 252K | 77K | 67K | 1M | |
-3.3M | 865K | -4M | -2.5M | -1.5M | 13.8M | -9.5M | -6.7M | -1.4M | 2.7M | 2.8M | -1.2M | -68K | |
-59.1M | -60.5M | -70.2M | -66.3M | -56.1M | -67.4M | -136M | -90.8M | -55.7M | -38M | -25.5M | -19.3M | -17.2M | |
INVESTING ACTIVITIES | |||||||||||||
-1.1M | -2.2M | -350K | -312K | -210K | -181K | -1M | -989K | -345K | -479K | -202K | -29K | -118K | |
(0.0) | (0.0) | (0.0) | -27.2M | (210K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-100.7M | -58M | -68.5M | -104.7M | -154.5M | (0.0) | (0.0) | -7.9M | -33.2M | -7.3M | (0.0) | (0.0) | (0.0) | |
48.4M | 93.1M | 158.6M | 131.9M | 6M | 0.0 | 0.0 | 28.4M | 20.3M | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 27.2M | -210K | 0.0 | 0.0 | 20.4M | -12.9M | -7.3M | 0.0 | 0.0 | 0.0 | |
-53.4M | (32.8M) | (89.7M) | (26.9M) | -148.7M | -181K | -1M | (19.4M) | -13.2M | -7.8M | -202K | -29K | -118K | |
FINANCING ACTIVITIES | |||||||||||||
100.7M | 18.4M | 7.4M | 34.2M | 200.4M | -26K | 26.8M | 149M | 67.6M | 46.2M | -12K | 15K | 0.0 | |
-20.4M | 10M | 1.2M | -2.9M | -2.8M | -10.1M | 73M | 42.9M | 4.9M | 10M | 0.0 | 9.9M | -2K | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -26K | (0.0) | (0.0) | (0.0) | (0.0) | -12K | (0.0) | (0.0) | |
-2.1M | -1.5M | 11.7M | -1.5M | -227K | -601K | -3.5M | 14K | -408K | -1.3M | 62K | 20.1M | 206K | |
78.2M | 26.8M | 20.4M | 41.8M | 220.1M | -10.1M | 96.2M | 192M | 72.1M | 54.9M | 10.7M | 30M | 204K | |
CASH FLOW SUMMARY | |||||||||||||
-34.4M | -797K | 39.9M | 2.3M | 15.3M | -77.7M | -40.9M | 120.6M | 3.1M | 9.1M | -15M | 10.7M | -17.1M | |
74.9M | 75.7M | 35.8M | 33.5M | 18.2M | 95.9M | 136.8M | 16.2M | 13M | 3.9M | 18.9M | 8.2M | 25.3M | |
40.5M | 74.9M | 75.7M | 35.8M | 33.5M | 18.2M | 95.9M | 136.8M | 16.2M | 13M | 3.9M | 18.9M | 8.2M | |
-60.2M | -62.7M | -70.5M | -66.6M | -56.3M | -67.6M | -137.1M | -91.8M | -56.1M | -38.5M | -25.7M | -19.3M | -17.3M |
SEC Filings
SENS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 20, 2026 | May 20, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 04, 2026 | May 01, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 01, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 06, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 02, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Related Guides
Continue your SENS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.